APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lower Extremity Exoskeleton Enhancement Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lower Extremity Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032

26 December 2025116 pages

Choose your research edition.

Industry ResearchLower Extremity Exoskeleton Enhancement Device Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Lower Extremity Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Lower Extremity Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lower Extremity Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Lower Extremity Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Lower Extremity Exoskeleton Enhancement Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lower Extremity Exoskeleton Enhancement Device include Alter G, B-TEMIA Inc., Cyberdyne, Ekso Bionics, Hocoma, Interactive Motion Technologies, LockHeed Martin, Myomo and Panasonic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lower Extremity Exoskeleton Enhancement Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lower Extremity Exoskeleton Enhancement Device market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lower Extremity Exoskeleton Enhancement Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lower Extremity Exoskeleton Enhancement Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lower Extremity Exoskeleton Enhancement Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lower Extremity Exoskeleton Enhancement Device Market by Company

Alter G

B-TEMIA Inc.

Cyberdyne

Ekso Bionics

Hocoma

Interactive Motion Technologies

LockHeed Martin

Myomo

Panasonic

Parker Hannifin

ReWalk Robotics

US Bionics

Pharos Medical Technology

Mile Bot

Shenzhen Ruihan Medical Technology

Siyi Intelligence

Lower Extremity Exoskeleton Enhancement Device Segment by Type

Smart Type

Conventional Type

Lower Extremity Exoskeleton Enhancement Device Segment by Application

Recovery Treatment

Industrial

Others

Lower Extremity Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Extremity Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Extremity Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Extremity Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lower Extremity Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lower Extremity Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Smart Type Table 2. Major Company of Conventional Type Table 3. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 5. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type (2021-2026) Table 8. Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2026) & (US$/Unit) Table 9. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 10. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type (2027-2032) Table 13. Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2027-2032) & (US$/Unit) Table 14. North America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 15. North America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 17. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 21. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (US$ Million) Table 24. Lower Extremity Exoskeleton Enhancement Device Industry Trends Table 25. Lower Extremity Exoskeleton Enhancement Device Industry Drivers Table 26. Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 27. Lower Extremity Exoskeleton Enhancement Device Industry Restraints Table 28. Global Lower Extremity Exoskeleton Enhancement Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Company (2021-2026) Table 30. Global Lower Extremity Exoskeleton Enhancement Device Sales by Company (2021-2026) & (Units) Table 31. Global Lower Extremity Exoskeleton Enhancement Device Sales Share by Company (2021-2026) Table 32. Global Lower Extremity Exoskeleton Enhancement Device Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Lower Extremity Exoskeleton Enhancement Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lower Extremity Exoskeleton Enhancement Device Major Company Production Sites and Headquarters Table 35. Global Lower Extremity Exoskeleton Enhancement Device Company, Product Type & Application Table 36. Global Lower Extremity Exoskeleton Enhancement Device Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lower Extremity Exoskeleton Enhancement Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lower Extremity Exoskeleton Enhancement Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 41. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Region (2021-2026) Table 44. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 46. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Region (2027-2032) Table 49. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 52. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application (2021-2026) Table 55. Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 57. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application (2027-2032) Table 60. Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2027-2032) & (US$/Unit) Table 61. North America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 62. North America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 64. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 68. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (US$ Million) Table 71. Alter G Company Information Table 72. Alter G Business Overview Table 73. Alter G Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 75. Alter G Recent Development Table 76. B-TEMIA Inc. Company Information Table 77. B-TEMIA Inc. Business Overview Table 78. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 80. B-TEMIA Inc. Recent Development Table 81. Cyberdyne Company Information Table 82. Cyberdyne Business Overview Table 83. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 85. Cyberdyne Recent Development Table 86. Ekso Bionics Company Information Table 87. Ekso Bionics Business Overview Table 88. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 90. Ekso Bionics Recent Development Table 91. Hocoma Company Information Table 92. Hocoma Business Overview Table 93. Hocoma Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 95. Hocoma Recent Development Table 96. Interactive Motion Technologies Company Information Table 97. Interactive Motion Technologies Business Overview Table 98. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 100. Interactive Motion Technologies Recent Development Table 101. LockHeed Martin Company Information Table 102. LockHeed Martin Business Overview Table 103. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 105. LockHeed Martin Recent Development Table 106. Myomo Company Information Table 107. Myomo Business Overview Table 108. Myomo Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 110. Myomo Recent Development Table 111. Panasonic Company Information Table 112. Panasonic Business Overview Table 113. Panasonic Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 115. Panasonic Recent Development Table 116. Parker Hannifin Company Information Table 117. Parker Hannifin Business Overview Table 118. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 120. Parker Hannifin Recent Development Table 121. ReWalk Robotics Company Information Table 122. ReWalk Robotics Business Overview Table 123. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 125. ReWalk Robotics Recent Development Table 126. US Bionics Company Information Table 127. US Bionics Business Overview Table 128. US Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 130. US Bionics Recent Development Table 131. Pharos Medical Technology Company Information Table 132. Pharos Medical Technology Business Overview Table 133. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 135. Pharos Medical Technology Recent Development Table 136. Mile Bot Company Information Table 137. Mile Bot Business Overview Table 138. Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 140. Mile Bot Recent Development Table 141. Shenzhen Ruihan Medical Technology Company Information Table 142. Shenzhen Ruihan Medical Technology Business Overview Table 143. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 145. Shenzhen Ruihan Medical Technology Recent Development Table 146. Siyi Intelligence Company Information Table 147. Siyi Intelligence Business Overview Table 148. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 150. Siyi Intelligence Recent Development Table 151. North America Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 152. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 153. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 154. North America Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 155. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 156. North America Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Lower Extremity Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 159. North America Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Lower Extremity Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 161. Europe Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 162. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 163. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 164. Europe Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 165. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Lower Extremity Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 169. Europe Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Lower Extremity Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 173. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 175. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 179. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 181. Latin America Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 182. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 183. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 184. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 185. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Lower Extremity Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 189. Latin America Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Lower Extremity Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 193. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032) & (Units) Table 195. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Share by Country (2021-2026) Table 199. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Lower Extremity Exoskeleton Enhancement Device Distributors List Table 204. Lower Extremity Exoskeleton Enhancement Device Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Lower Extremity Exoskeleton Enhancement Device Image Figure 2. Global Lower Extremity Exoskeleton Enhancement Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lower Extremity Exoskeleton Enhancement Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Lower Extremity Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 5. Smart Type Image Figure 6. Global Smart Type Sales YoY Growth (2021-2032) & (Units) Figure 7. Conventional Type Image Figure 8. Global Conventional Type Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Lower Extremity Exoskeleton Enhancement Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lower Extremity Exoskeleton Enhancement Device Market Share by Type 2025 VS 2032 Figure 11. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 12. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 13. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lower Extremity Exoskeleton Enhancement Device Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Recovery Treatment Image Figure 24. Global Recovery Treatment Sales YoY Growth (2021-2032) & (Units) Figure 25. Industrial Image Figure 26. Global Industrial Sales YoY Growth (2021-2032) & (Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Lower Extremity Exoskeleton Enhancement Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lower Extremity Exoskeleton Enhancement Device Market Share by Application 2025 VS 2032 Figure 31. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 32. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 33. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share in Value by Application in 2025 Figure 41. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Lower Extremity Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lower Extremity Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Lower Extremity Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lower Extremity Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lower Extremity Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lower Extremity Exoskeleton Enhancement Device Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lower Extremity Exoskeleton Enhancement Device Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Smart Type
  • Conventional Type
Applications
  • Recovery Treatment
  • Industrial
  • Others
Companies covered
  • Alter G
  • B-TEMIA Inc.
  • Cyberdyne
  • Ekso Bionics
  • Hocoma
  • Interactive Motion Technologies
  • LockHeed Martin
  • Myomo
  • Panasonic
  • Parker Hannifin
  • ReWalk Robotics
  • US Bionics
  • Pharos Medical Technology
  • Mile Bot
  • Shenzhen Ruihan Medical Technology
  • Siyi Intelligence

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lower Extremity Exoskeleton Enhancement Device Market by Type
  6. 1.3.1 Smart Type
  7. 1.3.2 Conventional Type
  8. 1.4 Global Lower Extremity Exoskeleton Enhancement Device Market Size by Type
  9. 1.4.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lower Extremity Exoskeleton Enhancement Device Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lower Extremity Exoskeleton Enhancement Device Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Lower Extremity Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Lower Extremity Exoskeleton Enhancement Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Lower Extremity Exoskeleton Enhancement Device Sales (2021-2026)
  3. 3.3 Global Top Players by Lower Extremity Exoskeleton Enhancement Device Price (2021-2026)
  4. 3.4 Global Lower Extremity Exoskeleton Enhancement Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lower Extremity Exoskeleton Enhancement Device Major Company Production Sites & Headquarters
  6. 3.6 Global Lower Extremity Exoskeleton Enhancement Device Company, Product Type & Application
  7. 3.7 Global Lower Extremity Exoskeleton Enhancement Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lower Extremity Exoskeleton Enhancement Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lower Extremity Exoskeleton Enhancement Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lower Extremity Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
4 Lower Extremity Exoskeleton Enhancement Device Regional Status and Outlook
  1. 4.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lower Extremity Exoskeleton Enhancement Device Historic Market Size by Region
  3. 4.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lower Extremity Exoskeleton Enhancement Device Forecasted Market Size by Region
  7. 4.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lower Extremity Exoskeleton Enhancement Device by Application
  1. 5.1 Lower Extremity Exoskeleton Enhancement Device Market by Application
  2. 5.1.1 Recovery Treatment
  3. 5.1.2 Industrial
  4. 5.1.3 Others
  5. 5.2 Global Lower Extremity Exoskeleton Enhancement Device Market Size by Application
  6. 5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lower Extremity Exoskeleton Enhancement Device Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alter G
  2. 6.1.1 Alter G Company Information
  3. 6.1.2 Alter G Business Overview
  4. 6.1.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  6. 6.1.5 Alter G Recent Developments
  7. 6.2 B-TEMIA Inc.
  8. 6.2.1 B-TEMIA Inc. Company Information
  9. 6.2.2 B-TEMIA Inc. Business Overview
  10. 6.2.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  12. 6.2.5 B-TEMIA Inc. Recent Developments
  13. 6.3 Cyberdyne
  14. 6.3.1 Cyberdyne Company Information
  15. 6.3.2 Cyberdyne Business Overview
  16. 6.3.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  18. 6.3.5 Cyberdyne Recent Developments
  19. 6.4 Ekso Bionics
  20. 6.4.1 Ekso Bionics Company Information
  21. 6.4.2 Ekso Bionics Business Overview
  22. 6.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  24. 6.4.5 Ekso Bionics Recent Developments
  25. 6.5 Hocoma
  26. 6.5.1 Hocoma Company Information
  27. 6.5.2 Hocoma Business Overview
  28. 6.5.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  30. 6.5.5 Hocoma Recent Developments
  31. 6.6 Interactive Motion Technologies
  32. 6.6.1 Interactive Motion Technologies Company Information
  33. 6.6.2 Interactive Motion Technologies Business Overview
  34. 6.6.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  36. 6.6.5 Interactive Motion Technologies Recent Developments
  37. 6.7 LockHeed Martin
  38. 6.7.1 LockHeed Martin Company Information
  39. 6.7.2 LockHeed Martin Business Overview
  40. 6.7.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  42. 6.7.5 LockHeed Martin Recent Developments
  43. 6.8 Myomo
  44. 6.8.1 Myomo Company Information
  45. 6.8.2 Myomo Business Overview
  46. 6.8.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  48. 6.8.5 Myomo Recent Developments
  49. 6.9 Panasonic
  50. 6.9.1 Panasonic Company Information
  51. 6.9.2 Panasonic Business Overview
  52. 6.9.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  54. 6.9.5 Panasonic Recent Developments
  55. 6.10 Parker Hannifin
  56. 6.10.1 Parker Hannifin Company Information
  57. 6.10.2 Parker Hannifin Business Overview
  58. 6.10.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  60. 6.10.5 Parker Hannifin Recent Developments
  61. 6.11 ReWalk Robotics
  62. 6.11.1 ReWalk Robotics Company Information
  63. 6.11.2 ReWalk Robotics Business Overview
  64. 6.11.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  66. 6.11.5 ReWalk Robotics Recent Developments
  67. 6.12 US Bionics
  68. 6.12.1 US Bionics Company Information
  69. 6.12.2 US Bionics Business Overview
  70. 6.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  72. 6.12.5 US Bionics Recent Developments
  73. 6.13 Pharos Medical Technology
  74. 6.13.1 Pharos Medical Technology Company Information
  75. 6.13.2 Pharos Medical Technology Business Overview
  76. 6.13.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  78. 6.13.5 Pharos Medical Technology Recent Developments
  79. 6.14 Mile Bot
  80. 6.14.1 Mile Bot Company Information
  81. 6.14.2 Mile Bot Business Overview
  82. 6.14.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  84. 6.14.5 Mile Bot Recent Developments
  85. 6.15 Shenzhen Ruihan Medical Technology
  86. 6.15.1 Shenzhen Ruihan Medical Technology Company Information
  87. 6.15.2 Shenzhen Ruihan Medical Technology Business Overview
  88. 6.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  90. 6.15.5 Shenzhen Ruihan Medical Technology Recent Developments
  91. 6.16 Siyi Intelligence
  92. 6.16.1 Siyi Intelligence Company Information
  93. 6.16.2 Siyi Intelligence Business Overview
  94. 6.16.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  96. 6.16.5 Siyi Intelligence Recent Developments
7 North America by Country
  1. 7.1 North America Lower Extremity Exoskeleton Enhancement Device Sales by Country
  2. 7.1.1 North America Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 7.1.3 North America Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  6. 7.2.1 North America Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country
  2. 8.1.1 Europe Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  6. 8.2.1 Europe Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country
  2. 9.1.1 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  6. 9.2.1 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lower Extremity Exoskeleton Enhancement Device Sales by Country
  2. 10.1.1 South America Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 10.1.3 South America Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  6. 10.2.1 South America Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country
  2. 11.1.1 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country
  6. 11.2.1 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lower Extremity Exoskeleton Enhancement Device Value Chain Analysis
  2. 12.1.1 Lower Extremity Exoskeleton Enhancement Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lower Extremity Exoskeleton Enhancement Device Production Mode & Process
  7. 12.2 Lower Extremity Exoskeleton Enhancement Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lower Extremity Exoskeleton Enhancement Device Distributors
  10. 12.2.3 Lower Extremity Exoskeleton Enhancement Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst